Citadel Advisors
NVNO

Citadel Advisors’s enVVeno Medical NVNO Stock Holding History

Citadel Advisors’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,221
Closed -$13.7K – 13830
2025
Q4 		$13.7K Sell
1,221
-345
-22% -$6.7K ﹤0.01% 12406
2025
Q3 		$49.7K Buy
1,566
+735
+88% +$75.1K ﹤0.01% 12217
2025
Q2 		$116K Buy
831
+76
+10% +$8.98K ﹤0.01% 11203
2025
Q1 		$69.5K Sell
755
-2,283
-75% -$254K ﹤0.01% 11920
2024
Q4 		$321K Buy
3,038
+3,009
+10,376% +$336K ﹤0.01% 9519
2024
Q3 		$3.38K Sell
29
-175
-86% -$32.1K ﹤0.01% 13662
2024
Q2 		$37.5K Sell
204
-1,098
-84% -$192K ﹤0.01% 12046
2024
Q1 		$248K Buy
1,302
+161
+14% +$28.9K ﹤0.01% 9881
2023
Q4 		$205K Buy
+1,141
New +$182K ﹤0.01% 9897
2023
Q3 		– Sell
-1,288
Closed -$139K – 14832
2023
Q2 		$139K Buy
+1,288
New +$167K ﹤0.01% 10442
2023
Q1 		– Sell
-317
Closed -$56.5K – 15251
2022
Q4 		$56.5K Sell
317
-254
-44% -$51.6K ﹤0.01% 11974
2022
Q3 		$126K Buy
+571
New +$122K ﹤0.01% 10885
2021
Q2 		– Sell
-329
Closed -$77K – 14173
2021
Q1 		$77K Buy
+329
New +$91.6K ﹤0.01% 12667
2020
Q4 		– Sell
-147
Closed -$56K – 11328
2020
Q3 		$56K Buy
+147
New +$49.8K ﹤0.01% 9561
2019
Q1 		– Sell
-16
Closed -$20K – 9685
2018
Q4 		$20K Buy
+16
New +$28.8K ﹤0.01% 8755

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's NVNO Position: Q1 2026 in Review

Citadel Advisors sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 1,221 shares — an estimated $13.7K sold.

Citadel Advisors first reported a position in NVNO in Q4 2018 and held it in 15 quarters. The position peaked at $321K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Citadel Advisors reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 1,221 enVVeno Medical shares in Q1 2026, an estimated $13.7K.
  • Citadel Advisors first reported a position in enVVeno Medical in Q4 2018 and held it in 15 quarters.
  • Citadel Advisors's enVVeno Medical position peaked at $321K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.